Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Source: Medical Xpress
Zepbound bests Wegovy for weight loss in new trial
430 Pennsylvania Ave.
Suite 350
Glen Ellyn, IL 60137
Tel:
3011 Butterfield Road
Suite 240
Oak Brook, IL 60523
Tel:
5101 S Willow Springs Road
Suite: Bariatric Clinic
La Grange, IL 60525
Tel:
